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Kalan and colleagues describe an unusual way of activating a ‘‘silent’’ gene cluster for the biosynthesis of a
new antibiotic by analyzing and curing the aerial growth defect of an old Streptomyces isolate, Streptomyces
calvus. This commentary addresses the broad scientific and historical context and practical and biological
significance of this finding.In their intriguing new study of Strepto-
myces calvus in this issue of Chemistry &
Biology, Kalan et al. (2013) show that
its inability to form a sporulating aerial
mycelium is due to a mutation in the
developmental gene bldA, and that com-
plementation of the mutation results in
production of a previously undiscovered
polyene antibiotic.
Streptomycetes have a mold-like col-
ony morphology. A vegetative (or sub-
strate) mycelium supports parasitic aerial
hyphae, which change into chains of
spores. This biomass recycling involves
controlled proteolysis of substrate myce-
lium and typically coincides with the pro-
duction of antibiotics, perhaps preventing
other organisms from pirating nutrients.
Most Streptomyces species produce
their own specific array of antibiotics,
and they have been the richest source
of such molecules for human use (Hop-
wood, 2007). In the search for novel
antibiotics, streptomycetes have been
isolated from almost every conceivable
ecological niche, and diverse fermenta-
tion conditions have been imposed to
maximize the chances of discovery.
More recently, genome sequencing has
shown that the ‘‘cryptic’’ or ‘‘silent’’
biosynthetic potential of any strain typi-
cally greatly exceeds the profile of
detected secondary metabolites (Challis,
2008). Ways of activating cryptic clusters
have therefore become of great interest.
It has long been known that a single
mutation can switch a streptomycete
from its ‘‘typical’’ colony phenotype to
a form that lacks aerial mycelium and
sporulation and is defective in much of
its antibiotic-producing capacity. Thus,
in the model organism S. coelicolor
(Hopwood 1967), genetic linkage analysis
revealed the cosegregation of the aerial
mycelium deficiency and lack of red-blue pigment of a mutant termed S48,
indicating that the complex phenotype
was due to mutation at a single locus.
Merrick (1976) pursued the analysis of
aerial mycelium-deficient mutants further
and gave the genes involved the general
name bld (for ‘‘bald,’’ because of the
mutants’ lack of a hairy surface). The
S48 mutation defined the first bld gene
‘‘bldA’’. Surprisingly, bldA (the first
Streptomyces developmental gene to be
cloned; Piret and Chater, 1985), proved
to determine a tRNA—the only one
capable of efficiently translating the
codon UUA, one of six encoding leucine
(Lawlor et al., 1987). This is the rarest
codon in Streptomyces, whose genes
have very high GC content. It transpired
that the bldA mutant phenotype was the
result of an inability to read UUA codons
in mRNAs of several particular genes:
key positive regulatory genes for the
blue polyketide antibiotic actinorhodin
and red prodiginine antibiotic undecyl-
prodigiosin, accounting for the pigment
deficiency of the mutant, and adpA,
encoding a global regulator of differen-
tiation and antibiotic production. In fact,
a TTA codon is found in the same position
in the adpA genes of nearly all streptomy-
cetes, making it the most highly
conserved TTA codon in the entire genus,
while a high proportion of the regulatory
genes associated with antibiotic biosyn-
thetic gene clusters in streptomycetes
contain a TTA codon (Chandra and
Chater, 2008; Chater and Chandra, 2008).
S. calvus (meaning ‘‘the bald strepto-
mycete’’) was isolated in the late 1950s
and produced a fluorinated nucleoside
antibiotic, nucleosidin (a finding that
proved hard to reproduce). Now, Kalan
et al. (2013) have explored the basis for
the bald phenotype of this strain. Genome
sequencing revealed a mutation in a keyChemistry & Biology 20, October 24, 2013 ªresidue of the bldA tRNA, and the intro-
duction of a functional bldA gene into
S. calvus restored the ability to produce
a sporulating aerial mycelium. Thus, in a
satisfying completion of the circle, the
bald streptomycete isolated in the 1950s
corresponded to the first bald mutant
to be characterized in the later era of
Streptomyces genetics.
High-performance liquid chromato-
graphy profiling of S. calvus carrying a
functional bldA gene revealed a previ-
ously undetected pair of peaks, which
were shown to be polyenes related to
Sch725424, which had been previously
isolated from a Kitasatospora strain. The
compounds were named 4-Z- and 4-E-
annimycins. Kalan et al. (2013) success-
fully identified the S. calvus gene cluster
responsible for annimycin biosynthesis
and showed that disruption of one of the
modular polyketide synthase genes in
the cluster eliminated annimycin produc-
tion. Curiously, no TTA codon was pre-
sent in the annimycin biosynthetic cluster,
leaving open the reason for its depen-
dence on bldA. However, the adpA gene
is one strong candidate as a TTA-contain-
ing regulator on the expectation (not
clarified by Kalan et al., 2013) that the
conserved TTA codon in adpA genes is
indeed present in the S. calvus version.
Although Kalan et al. (2013) raise the
possibility that the introduction of a copy
of bldAmight cause other streptomycetes
with poor sporulation to express cryptic
biosynthetic potential, they emphasize
that causes other than bldA mutation
might be responsible for such morpho-
logical defects. The wider utility of the
effect of bldA reported in this paper will
therefore require further experimental
assessment. However, it is interesting
that bald S. calvus produces at least one
secondary metabolite (a nonribosomal2013 Elsevier Ltd All rights reserved 1199
Figure 1. Potential Benefits of Hypothetical Phase Variation between Functional and Nonfunctional States of bldA
The model is predicated on the finding of a natural bldAmutant of S. calvus that readily reverts to wild-type (wt) status in the laboratory. No molecular mechanism
for the variation is suggested. Pros and cons of the alternative states are shown in the side text. For further discussion, see the main text. Images courtesy of
B.K. Leskiw.
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Previewspeptide) abundantly, since secondary
metabolite production is generally nega-
tively affected by bldAmutations. Produc-
tion of any metabolite in a bldA mutant,
with its very limited capacity for second-
ary metabolism, makes product puri-
fication and analysis easier as well as
reducing competition for precursors. In
earlier studies, it was relatively straight-
forward to introduce mutant bldA alleles
into the S. coelicolor chromosome (Piret
and Chater, 1985), so it may be worth
devising an efficient system for doing
this in other species.
Could the bldA mutant status of
S. calvus have any adaptive benefit? A
remarkable observation in the paper by
Kalan et al. (2013) is the apparent ease
of obtaining spontaneous sporulating
derivatives in which the disruptive G resi-
due in the D arm of the bldA tRNA was re-
placed by the A residue found in wild-type
bldA tRNAs of other streptomycetes. The
authors do not quantify the frequency of
these mutations, but, for a specific base
change, they seem surprisingly readily
obtained. It would be interesting to know
whether such revertants could easily
undergo mutation back to the mutant
form again, in a kind of phase-change,
because one can imagine some selective
advantages to a bldA mutant over an
equivalent sporulating strain (Figure 1).1200 Chemistry & Biology 20, October 24, 20First of all, at least in S. coelicolor, a
bldA mutant grew more rapidly and to a
higher cell density under some fermenta-
tion conditions than its parent (Kim et al.,
2008). Second, oscillation between bldA
states would dramatically change the
spectrum of secondary metabolites pro-
duced, presenting completely alternative
faces to neighbors in their natural habi-
tats. There are growing recent examples
of ecologically significant interplay be-
tween neighboring bacteria mediated by
secondary metabolites (Romero et al.,
2011), and, indeed, Kalan et al. (2013)
found that annimycins inhibited aerial
mycelium formation of other strptomy-
cetes. Third, the inability of bldA mutants
to express UUA-containingmRNAswould
make them unproductive hosts for bacte-
riophages with TTA codons in genes
essential for lysis. Finally, since the effects
of bldA mutation are mostly exerted
on the complex extracellular biology of
streptomycetes (Chater et al., 2010),
bldA mutants might effectively cheat by
borrowing extracellular material supplied
by neighboring bldA+ streptomycetes.
This may be why bldAmutant segregants
showed no apparent numerical deficiency
among the spores harvested from early
crosses between strains differing in their
bldA status (Hopwood, 1967; Merrick,
1976).13 ª2013 Elsevier Ltd All rights reservedREFERENCES
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